Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nano-in-Micro-Particles Consisting of PLGA Nanoparticles Embedded in Chitosan Microparticles via Spray-Drying Enhances Their Uptake in the Olfactory Mucosa.
Spindler LM, Feuerhake A, Ladel S, Günday C, Flamm J, Günday-Türeli N, Türeli E, Tovar GEM, Schindowski K, Gruber-Traub C. Spindler LM, et al. Among authors: flamm j. Front Pharmacol. 2021 Sep 1;12:732954. doi: 10.3389/fphar.2021.732954. eCollection 2021. Front Pharmacol. 2021. PMID: 34539414 Free PMC article.
Selective CNS Targeting and Distribution with a Refined Region-Specific Intranasal Delivery Technique via the Olfactory Mucosa.
Maigler F, Ladel S, Flamm J, Gänger S, Kurpiers B, Kiderlen S, Völk R, Hamp C, Hartung S, Spiegel S, Soleimanizadeh A, Eberle K, Hermann R, Krainer L, Pitzer C, Schindowski K. Maigler F, et al. Among authors: flamm j. Pharmaceutics. 2021 Nov 10;13(11):1904. doi: 10.3390/pharmaceutics13111904. Pharmaceutics. 2021. PMID: 34834319 Free PMC article.
Intranasal Nose-to-Brain Drug Delivery via the Olfactory Region in Mice: Two In-Depth Protocols for Region-Specific Intranasal Application of Antibodies and for Expression Analysis of Fc Receptors via In Situ Hybridization in the Nasal Mucosa.
Herzog H, Glöckler S, Flamm J, Ladel S, Maigler F, Pitzer C, Schindowski K. Herzog H, et al. Among authors: flamm j. Methods Mol Biol. 2024;2754:387-410. doi: 10.1007/978-1-0716-3629-9_21. Methods Mol Biol. 2024. PMID: 38512678
HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial.
Wohl DA, Spinner CD, Flamm J, Hare CB, Doblecki-Lewis S, Ruane PJ, Molina JM, Mills A, Brinson C, Ramgopal M, Clarke A, Crofoot G, Martorell C, Carter C, Cox S, Hojilla JC, Shao Y, Das M, Kintu A, Baeten JM, Grant RM, Mounzer K, Mayer K. Wohl DA, et al. Among authors: flamm j. Lancet HIV. 2024 Aug;11(8):e508-e521. doi: 10.1016/S2352-3018(24)00130-9. Epub 2024 Jul 14. Lancet HIV. 2024. PMID: 39008999 Clinical Trial.
Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care.
Mian MN, Sarovar V, Levine T, Lea A, Leibowitz A, Luu M, Flamm J, Hare CB, Horberg M, Young-Wolff KC, Phillips KT, Silverberg MJ, Satre DD. Mian MN, et al. Among authors: flamm j. Res Sq [Preprint]. 2024 May 29:rs.3.rs-4415444. doi: 10.21203/rs.3.rs-4415444/v1. Res Sq. 2024. PMID: 38853848 Free PMC article. Preprint.
145 results